A Comparative Study of Statistical Methods to Assess Dilutional Similarity - The four parameter logistic model is a better control method than the dilution effect statistic - BioPharm International

ADVERTISEMENT

A Comparative Study of Statistical Methods to Assess Dilutional Similarity
The four parameter logistic model is a better control method than the dilution effect statistic


BioPharm International


Using 95% confidence level, the assumption of parallelism will be rejected if F is larger than the critical point from an F distribution with 3 numerator degrees of freedom and (n–8) denominator degrees of freedom, where n is the total number of observations in the analysis.

COMPARISON OF THE METHODS


Figure 1. Total RNA Yield (mg) from Different Tissues (mg) The upper asymptotes do not match. Dilutional similarity rejected by F-test.
As part of the release of a drug product as a reference standard, a qualification study was undertaken to compare the potency between the new formulation with the original reference standard, STD. Figures 1– 5 are graphs comparing a test sample to a reference standard using a 4-parameter logistic model. These are independent tests of the formulations and not a sequence.


Figure 2. Yield of Total and mRNA from Different Tissues and Cells Divergence at higher concentrations. Dilutional similarity rejected by F-test.
The compounds were radio-tagged, depicting the measurement in counts/min. The starting point of each test is 200 mg/mL and then it is diluted in steps of 3-fold or 2-fold until the last measurement at 0.77 mg/mL. On all figures the x-axis is logarithmic and the y-axis is linear.

In order to compute the potency, the test sample has to be parallel to the reference standard. In Figure 1, the test sample and the reference standard do not have the same upper asymptote. The F-statistic was 3.67 with p-value = 0.0436 < 0.05 rejecting the dilutional similarity. However, the dilution effect computed was 5.95%, which did not reject the parallelism because it is ≤ 20%. In Figure 2 and Figure 3, the test of parallelism was rejected using F-statistics. The p-values were < 0.0001 and 0.0004, respectively. The dilution effects statistics computed were 16.89% and 19.31%, respectively, yielding an acceptance result for dilutional similarity, as it was ≤ 20%.

In Figure 4, the test of parallelism yielded a p-value of 0.992, which is ≥ 0.05 and the dilution effect measure computed was less than 20%. The two tests had comparable outcomes. In Figure 5, the two tests rejected the dilutional similarity.


blog comments powered by Disqus

ADVERTISEMENT

Cobra Biologics Announces Development Projects
June 14, 2013
Supreme Court: Human Genes Are Not Patentable
June 14, 2013
ISPE Study Reports on Root Causes for Drug Shortages
June 12, 2013
Elan Board Rejects Multibillion Takeover Bid from Royalty Pharma
June 11, 2013
EMA Revises Biosimilars Guideline
June 11, 2013
Upcoming Conferences
UPCOMING CONFERENCES

Access Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA | July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA | August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA | August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA | August 20-21, 2013
Request Brochure

See All Conferences >>

ADVERTISEMENT

Author Guidelines
FindPharma
Source: BioPharm International,
Click here